Delivery Order SPE2DR25D3301-SPE2DR26F19AV
Award Date 12/5/25
Potential Completion Date 12/8/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This delivery order, awarded on September 26, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, is for the supply of Tabloid 40 mg tablets in quantities of 25 units. The contract is valued at $58,572.86 with a firm fixed price structure and an ultimate completion date of September 29, 2025. There is no set-aside designation associated with this award, indicating it was competitively awarded through open procurement. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $10,641.07 to AmerisourceBergen Drug Corp for 30 tablets of TAGRISSO 40 MG, a targeted cancer therapy medication. This firm fixed price delivery order, issued on July 30, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 through December 2026. The delivery location is AmerisourceBergen's corporate office in...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of TABLOID 40 MG TABLET 25S, with a completion date of February 15, 2024 and a potential value of $13,483.08. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp has received numerous federal contract awards from DLA...
- The Defense Logistics Agency (DLA) awarded a $21,325.14 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Tagrisso 80 mg, a prescription oncology medication used in cancer treatment. The contract, awarded on July 31, 2025, with an ultimate completion date of August 21, 2025, utilizes firm fixed price pricing with no set-aside designation, indicating the award was competitively procured. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for WELIREG 40 mg tablets (90-count supply) on August 26, 2025, with completion scheduled for September 17, 2025. This firm fixed-price delivery order represents a non-competitive award under a larger contract vehicle and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $4,337.55 to AmerisourceBergen Drug Corp for the supply of Qualiptа 30 mg tablets (30-count) on July 23, 2025, with completion targeted for July 24, 2025. This firm fixed-price delivery order represents a non-competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that...
- The Defense Logistics Agency awarded a $21,325.14 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Tagrisso 80 mg, a targeted cancer therapy medication. The contract represents a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a $13,083.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TIVDAK 40 mg vials, with an ultimate completion date of June 24, 2025. This non-set-aside delivery order represents a single pharmaceutical procurement under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for TRUQAP 160 mg tablets on July 10, 2025, with a ceiling value of $15,658.94 and ultimate completion by July 31, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a delivery order valued at $7,277.80 to AmerisourceBergen Drug Corp for Qualipita 60 mg tablets (30-count units) on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to...